See more : Gunther Grant, Inc. (GNGR) Income Statement Analysis – Financial Results
Complete financial analysis of Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nath Bio-Genes (India) Limited, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Yibin Tianyuan Group Co., Ltd. (002386.SZ) Income Statement Analysis – Financial Results
- Gaming Innovation Group Inc. (GIG.OL) Income Statement Analysis – Financial Results
- Honghua Group Limited (0196.HK) Income Statement Analysis – Financial Results
- Deceuninck NV (DECB.BR) Income Statement Analysis – Financial Results
- Nuix Limited (NXL.AX) Income Statement Analysis – Financial Results
Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
About Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers seeds for cereals, such as maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, including cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green paeas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements, such as WINPro GOLii, WINall, and Win Chi Win growth enhancer; and forage supplements, including NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The company offers its products through a network of distributors, dealers, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.48B | 3.01B | 2.78B | 3.07B | 2.80B | 2.31B | 1.92B | 1.70B | 1.62B | 1.85B | 1.89B | 1.38B | 1.24B |
| Cost of Revenue | 1.44B | 1.35B | 1.24B | 1.36B | 1.28B | 1.08B | 848.36M | 710.86M | 545.35M | 582.36M | 601.72M | 532.08M | 503.43M |
| Gross Profit | 1.03B | 1.67B | 1.54B | 1.71B | 1.52B | 1.23B | 1.07B | 986.40M | 1.08B | 1.27B | 1.29B | 844.94M | 735.72M |
| Gross Profit Ratio | 41.66% | 55.33% | 55.46% | 55.72% | 54.41% | 53.19% | 55.73% | 58.12% | 66.36% | 68.58% | 68.23% | 61.36% | 59.37% |
| Research & Development | 112.76M | 93.71M | 88.85M | 91.54M | 91.03M | 25.70M | 78.79M | 86.74M | 111.17M | 122.29M | 106.32M | 90.69M | 71.90M |
| General & Administrative | 72.86M | 54.16M | 66.01M | 50.92M | 50.80M | 56.21M | 58.08M | 39.99M | 40.64M | 29.66M | 72.95M | 55.98M | 45.12M |
| Selling & Marketing | 276.37M | 707.78M | 198.15M | 212.01M | 241.39M | 178.10M | 119.05M | 103.54M | 140.00M | 142.38M | 650.08M | 397.07M | 365.81M |
| SG&A | 349.23M | 707.78M | 264.16M | 262.92M | 292.19M | 234.31M | 177.13M | 143.54M | 180.64M | 172.03M | 723.03M | 453.04M | 410.93M |
| Other Expenses | 92.13M | 5.60M | 973.00K | 700.04K | 417.16K | 459.71K | 435.20K | 5.38M | 4.77M | 4.63M | 170.44M | 141.69M | 130.87M |
| Operating Expenses | 554.12M | 1.21B | 1.20B | 1.07B | 987.90M | 804.24M | 652.97M | 719.88M | 861.16M | 965.92M | 999.79M | 685.43M | 613.70M |
| Cost & Expenses | 2.00B | 2.55B | 2.44B | 2.43B | 2.26B | 1.88B | 1.50B | 1.43B | 1.41B | 1.55B | 1.60B | 1.22B | 1.12B |
| Interest Income | 3.22M | 179.00K | 10.93M | 12.14M | 13.02M | 17.29M | 4.99M | 34.61K | 599.14K | 88.66K | 60.03K | 118.11K | 619.31K |
| Interest Expense | 91.11M | 101.21M | 101.25M | 79.02M | 63.37M | 49.38M | 99.10M | 91.46M | 56.31M | 42.03M | 37.19M | 35.61M | 18.06M |
| Depreciation & Amortization | 32.61M | 30.12M | 30.84M | 28.16M | 14.53M | 14.47M | 9.51M | 30.30M | 39.05M | 43.87M | 46.61M | 45.10M | 47.00M |
| EBITDA | 536.39M | 488.91M | -497.06M | 684.33M | 566.15M | 434.38M | 407.55M | 289.73M | 251.29M | 350.70M | 341.93M | 203.49M | 169.02M |
| EBITDA Ratio | 21.67% | 16.41% | 13.82% | 21.96% | 20.08% | 19.63% | 22.16% | 17.46% | 15.53% | 18.83% | 17.91% | 14.85% | 14.76% |
| Operating Income | 477.02M | 457.34M | 345.70M | 643.36M | 533.65M | 419.92M | 414.99M | 167.53M | 214.55M | 304.98M | 255.13M | 122.96M | 90.75M |
| Operating Income Ratio | 19.27% | 15.18% | 12.42% | 20.93% | 19.07% | 18.21% | 21.66% | 9.87% | 13.23% | 16.46% | 13.47% | 8.93% | 7.32% |
| Total Other Income/Expenses | -61.37M | -105.66M | -991.59M | -84.84M | -49.91M | -33.37M | -99.74M | -96.82M | -55.20M | -41.45M | -86.20M | -34.50M | 1.00 |
| Income Before Tax | 415.65M | 363.18M | -633.90M | 567.51M | 485.08M | 388.68M | 300.54M | 167.53M | 152.16M | 263.53M | 255.13M | 122.96M | 90.75M |
| Income Before Tax Ratio | 16.79% | 12.05% | -22.77% | 18.46% | 17.33% | 16.86% | 15.68% | 9.87% | 9.39% | 14.22% | 13.47% | 8.93% | 7.32% |
| Income Tax Expense | 19.46M | 11.53M | 39.52M | 10.89M | -19.76M | 4.35M | 6.36M | 4.71M | 10.48M | 9.55M | 12.09M | 5.50M | -1.26M |
| Net Income | 396.19M | 350.11M | -673.38M | 556.62M | 504.84M | 384.33M | 294.19M | 162.82M | 141.67M | 253.97M | 243.04M | 117.46M | 92.01M |
| Net Income Ratio | 16.01% | 11.62% | -24.19% | 18.11% | 18.04% | 16.67% | 15.35% | 9.59% | 8.74% | 13.70% | 12.83% | 8.53% | 7.42% |
| EPS | 20.85 | 18.42 | -35.43 | 29.29 | 26.57 | 20.22 | 17.83 | 10.17 | 8.85 | 15.87 | 15.19 | 0.73 | 5.75 |
| EPS Diluted | 20.85 | 18.42 | -35.43 | 29.29 | 26.57 | 20.22 | 17.31 | 10.17 | 8.85 | 15.87 | 15.19 | 0.73 | 5.75 |
| Weighted Avg Shares Out | 19.00M | 19.00M | 19.00M | 19.00M | 19.00M | 19.00M | 16.50M | 16.00M | 16.00M | 16.00M | 16.00M | 16.00M | 16.00M |
| Weighted Avg Shares Out (Dil) | 19.00M | 19.00M | 19.00M | 19.00M | 19.00M | 19.00M | 16.99M | 16.00M | 16.00M | 16.00M | 16.00M | 16.00M | 16.00M |
Source: https://incomestatements.info
Category: Stock Reports